Could a pill beat long COVID fatigue? new trial aims to find out
NCT ID NCT06597396
First seen Oct 31, 2025 · Last updated May 22, 2026 · Updated 30 times
Summary
This study tests whether a daily pill called abrocitinib can reduce severe tiredness in adults with Long COVID. About 46 people who were never hospitalized for COVID will take either a low dose, a higher dose, or a placebo for 12 weeks. Researchers will measure changes in fatigue and overall health using standard questionnaires.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FATIGUE SYMPTOM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.